• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Arrowhead Pharma (NQ: ARWR )

    21.39 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Arrowhead Pharma

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q2 2024
    ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma
    Via Benzinga
    Recap: Arrowhead Pharma Q1 Earnings
    Via Benzinga
    Earnings Scheduled For February 6, 2024
    Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
    Via Benzinga
    Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
    Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses... 
    Via Benzinga
    Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter Results
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Turnstone Biologics Appoints William Waddill to its Board of Directors
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024
    With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April. 
    Via InvestorPlace
    NetApp, Zoom Video And 2 Other Stocks Insiders Are Selling
    The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
    Via Benzinga
    Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    7 Biotech Stocks to Buy as Sector Rotation Ramps Up
    With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation. 
    Via InvestorPlace
    The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024
    The Russell 2000 is up about 4% year to date, and could push higher, taking the most undervalued Russell 2000 stocks along for the ride. 
    Via InvestorPlace
    EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
    U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
    U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    7 Oversold Russell 2000 Stocks to Add to Your February Buy List
    Investors may want to jump into oversold Russell 2000 stocks. After a rough outing in 2023, many are starting to come back strong. 
    Via InvestorPlace
    Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
    Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
    Via Investor's Business Daily
    7 Biotech Stocks Fighting America’s Deadliest Diseases
    Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    Arrowhead Pharmaceuticals to Webcast Fiscal 2024 First Quarter Results
    From Arrowhead Pharmaceuticals, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.